Matt is the development program team leader for niraparib at TESARO, responsible for leading the core team to collaborate in the developing program strategy, scenario planning and program recommendations. Prior to TESARO, Matt worked in program management at ArQule and Synta Pharmaceuticals, where he led cross functional development teams for a number of targets and molecules in oncology and autoimmune disease. Before that, Matt consulted to numerous biotechnology and medical device companies as project team leader at the strategy consulting firm Health Advances. Matt received his MS in Cell and Molecular Biology from the University of Pennsylvania, and an SB in Biology from MIT.